What's New in USP <795>
On November 1, 2022, the United States Pharmacopeia (USP) published the revised General Chapter <795> Pharmaceutical Compounding – Nonsterile Preparations, after many years of discussions, appeals, and amendments. The chapter is set to be compendially official on November 1, 2023 and pharmacies are tasked with getting their processes and operations up-to-speed fast to ensure compliance.
In this webinar we break down the new requirements of USP <795> in a convenient compare-contrast approach that facilitates your transition from the current to the new. Knowing is one thing, doing is another. To support your transition we have additional resources and support that will be covered in this program. The end goal is to get you ready for your 8-month sprint toward compliance.
- Pharmacists & Pharmacy Technicians
|Single-core 1Ghz or higher
|Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent)
This webinar is Copyright © 2023 LP3 Network
DAVID MASTROPIETRO, PhD, RPh
Dr. David Mastropietro is an Assistant Professor of Pharmaceutical Sciences at Nova Southeastern University, College of Pharmacy where he teaches the art of pharmacy compounding and the science of formulation development using classroom and laboratory methodologies. Dr. Mastropietro is also a pharmacist with over 20 years of experience practicing in community and hospital settings. He has 8 years’ experience consulting in the development, testing, and manufacturing of dietary supplements, serving as Senior Advisor for Formulation Development & Product Commercialization for Solara Labs, Inc. and Director of Personalized Formulation & Experience for Clean Living & Wellness. In addition to his teaching, pharmacist, and advisory roles, Dr. Mastropietro is active in research with 24 journal publications, over 85 abstracts and presentations, 3 book chapters, and 7 US & World patent applications.
Please note that this webinar is not accredited / does not offer any CE credit.